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Background: Studies investigating the association between the apolipoprotein E (APOE) gene polymorphism and
the risk of intracerebral hemorrhage (ICH) have reported conflicting results. We here performed a meta-analysis
based on the evidence currently available from the literature to make a more precise estimation of this relationship.
Methods: Published literature from the National Library of Medline and Embase databases were retrieved. Odds
ratio (OR) and 95% confidence interval (CI) were calculated in fixed- or random-effects models when appropriate.
Subgroup analyses were performed by race.
Results: This meta-analysis included 11 case–control studies, which included 1,238 ICH cases and 3,575 controls.
The combined results based on all studies showed that ICH cases had a significantly higher frequency of APOE ε4
allele (OR= 1.42, 95% CI= 1.21,1.67, P<0.001). In the subgroup analysis by race, we also found that ICH cases had a
significantly higher frequency of APOE ε4 allele in Asians (OR= 1.52, 95% CI= 1.20,1.93, P<0.001) and in Caucasians
(OR= 1.34, 95% CI= 1.07,1.66, P=0.009). There was no significant relationship between APOE ε2 allele and the risk of ICH.
Conclusion: Our meta-analysis suggested that APOE ε4 allele was associated with a higher risk of ICH.
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Intracerebral hemorrhage (ICH) occurs at an annual in-
cidence rate of 15 to 19 per 100,000 [1]. ICH accounts
for approximately 15% of acute strokes in the United
States and 22–35% in Asian populations [2-5]. ICH can be
a devastating type of stroke, and the 30-day case mortality
rate of ICH is 40% to 50%. [2,6]. A pooled prospective
study found that the risk factors for ICH were older age,
African-American ethnicity, hypertension, lower LDL-C,
and lower triglycerides [7]. ICH has been shown to have
important genetic and environmental risk factors.
Apolipoprotein E (APOE) gene, located on the long
arm of chromosome 19, codes for a 299-amino acid pro-
tein (apoE). ApoE is a polymorphic glycoprotein in-
volved in cholesterol transport and cell membrane
maintenance and repair [8,9]. APOE has three common* Correspondence: xfwang13@hotmail.com
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unless otherwise stated.alleles: epsilon 2 (ε2), ε3, and ε4 that encode the three
major isoforms of apoE: E2, E3, and E4, which performs
isoform-dependent neurotrophic and antioxidant func-
tions [8,10-12]. Each person has 2 alleles that together
compose that person’s APOE genotype (e.g., ε2/ε3 or ε3/
ε3). APOE is one of the most widely studied genes in
vascular and neurodegenerative diseases [13].
Recently, some studies have been conducted to clarify
the association between APOE gene polymorphisms and
the risk of ICH [14-24]. However, previous studies inves-
tigating the association have reported conflicting results
[25,26]. We here performed a meta-analysis based on
the evidence currently available from the literature to
make a more precise estimation of this relationship.Materials and methods
Literature search strategy
We used a detailed electronic search strategy in Medline
and Embase from 1950 to the end of March 2013. TwoLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lowing key words in all relevant combinations: ‘cerebral’
or ‘intracerebral’ or ‘intracranial’, ‘hemorrhage’, ‘apolipo-
protein E*’ or ‘ApoE*’, ‘polymorphism’ or ‘allele’ or ‘geno-
type’ or ‘variant’. The search was conducted without
limitation on language. The reference lists of all re-
trieved publications were scrutinized for additional stud-
ies. If studies had partially overlapping subjects, the
smaller dataset was excluded. If necessary, we attempted
to contact the principal investigators of retrieved articles
to require additional data.
Inclusion and exclusion criteria
The following criteria were used to include published
studies: (i) independent epidemiological studies (for
humans only); (ii) a clear description of APOE allele in
ICH cases and controls; (iii) sufficient allele data were
presented to calculate the odds ratio (OR) and 95% con-
fidence interval (CI); Major reasons for exclusion of
studies were (i) no control; (ii) not an original paper (e.g.
review or letter etc.); (iii) duplicate publications.
Data extraction
Data were extracted by two authors independently, and
disagreements were resolved by consensus. When a
study did not explicitly report one or more of the re-
quested data, we contacted the author of the study for
additional details. The following data were extracted: the
last name of the first author, publication year, country,
study design, genotyping method, sample size and the
results of studies.
Statistical analysis
All analyses were performed using STATA 11.0 (Stata-
Corp LP, College Station, TX, USA). The Mantel-Haenszel
method for fixed effects and the Der-Simonian-LairdTable 1 Characteristics of studies included in the meta-analys
Study (author, year) Design Study period Population (countr
Nakata 1997 HCC 1992-1995 Asians (Japan)
McCarron 1998 HCC DNR Caucasians (United K
Garcia 1999 PCC DNR Caucasians (Portugal
Kokubo 2000 PCC 1997-1999 Asians (Japan)
Catto 2000 HCC 1997 Caucasians (United K
Chowdhury 2001 HCC 1998-1999 Asians (Japan)
Woo 2002 PCC 1997-2000 Caucasians (USA)
Woo 2005 HCC 1997-2002 Caucasians (USA)
Chen 2009 HCC DNR Asians (China)
Zhang 2012 HCC 2008-2010 Asians (China)
Misra 2012 HCC DNR Asians (India)
Abbreviations: HCC Hospital-based case–control, PCC Population-based case–control
fragment length polymorphism.method for random effects were used to estimate pooled
OR and corresponding 95% CI. Meta-analysis heterogen-
eity was quantified by computing Cochrane’s Q and corre-
sponding P-value and I2 (percent of effect size attributable
to heterogeneity). We used fixed-effects methods if the re-
sult of the Q test was not significant. Otherwise, we calcu-
lated pooled estimates and confidence intervals assuming
a random-effects model. Also, subgroup analyses were
performed on the basis of race. In this study, P < 0.05 was
considered statistically significant. Publication bias was
assessed by visual inspection of funnel plots, the Begg's




Characteristics of studies included in the meta-analysis
are summarized in Table 1. Our initial search identified
108 studies according to the search words. Through the
step of screening the title, abstracts, 85 articles were ex-
cluded, leaving 23 articles for full publication review. Of
these, 12 were excluded [25-36]. Finally, a total of 11
studies were included in our meta-analysis [14-24],
which included 1,238 ICH cases and 3,575 controls. Of
those, three studies were population-based case–control
studies, and eight studies were hospital-based case–con-
trol studies. Studies were conducted in USA, United
Kingdom, Portugal, Japan, India and China. The fre-
quencies of apolipoprotein E alleles of studies included
in the meta-analysis were shown in Table 2.
Quantitative synthesis
The combined results based on all studies showed that
ICH cases had a significantly higher frequency of APOE
ε4 allele (OR= 1.42, 95% CI= 1.21,1.67, P<0.001) (Figure 1)
(Table 3). In the subgroup analysis by race, we also foundis
y) Genotyping method No. of cases No. of controls
PCR 38 38
ingdom) PCR 71 406
) PCR-RFLP 48 173
PCR-RFLP 84 1126







, DNR Data not reported, PCR Polymerase chain reaction, RFLP Restriction
Table 2 Frequencies of apolipoprotein E alleles of studies included in the meta-analysis
Study (author, year) ε2 of cases ε3 of cases ε4 of cases ε2 of controls ε3 of controls ε4 of controls
Nakata 1997 3 32 3 2 32 4
McCarron 1998 18 89 35 66 599 147
Garcia 1999 4 84 8 14 298 34
Kokubo 2000 14 131 23 103 1913 236
Catto 2000 5 95 20 44 446 88
Chowdhury 2001 2 146 12 13 333 34
Woo 2002 39 96 53 64 206 96
Woo 2005 15 118 39 25 266 48
Chen 2009 33 359 42 44 479 37
Zhang 2012 26 280 54 26 314 20
Misra 2012 7 183 10 15 343 18
Figure 1 Meta-analysis of APOE alleles and ICH (ε4 versus ε3).
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Table 3 Meta-analysis of apolipoprotein E alleles and intracerebral hemorrhage risk
No. of
studies
OR (95% CI) P of OR P of
heterogeneity
OR (95% CI) P of OR P of
heterogeneityε4 versus ε3 ε2 versus ε3
All 11 1.42 (1.21,1.67) <0.001 0.09 1.18 (0.96,1.44) 0.11 0.29
Asians 6 1.52 (1.20,1.93) <0.001 0.05 1.11 (0.83,1.47) 0.47 0.25
Caucasians 5 1.34 (1.07,1.66) 0.009 0.32 1.26 (0.94,1.68) 0.12 0.28
Abbreviations: OR Odds ratio, CI Confidence interval.
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APOE ε4 allele in Asians (OR= 1.52, 95% CI= 1.20,1.93,
P<0.001) and in Caucasians (OR= 1.34, 95% CI= 1.07,1.66,
P=0.009) (Figure 1) (Table 3). There was no significant re-
lationship between APOE ε2 allele and the risk of ICH
(Figure 2) (Table 3).
Heterogeneity analysis and publication bias
Statistical heterogeneity was not found among studies in
overall comparisons by using the Q statistic (Table 3). Pub-
lication bias was not found by the Begg's rank correlationFigure 2 Meta-analysis of APOE alleles and ICH (ε2 versus ε3).method (Figure 3) or Egger weighted regression method
(Figure 4).
Discussion
There is evidence for a role of genetic factors in the devel-
opment of ICH. Studies investigating the association be-
tween genetic polymorphisms and ICH risk are being
reported with rapidly increasing frequency. Endoglin gene
polymorphism was a risk factor for sporadic ICH [37]. A
comparative study that angiotensin converting enzyme
(ACE) gene DD homozygosity of the I/D polymorphism in
Figure 3 Begg’s publication bias plot of APOE alleles and ICH.
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population [38]. A case–control study suggested that the
beta1-tubulin Q43P polymorphism could be associated
with ICH in men from southern Spain [39]. A population-
based prospective nested case–control study found that
estrogen receptor alpha gene polymorphisms were associ-
ated with first-ever ICH, particularly in combination with
hypertension [40]. A case–control study found that gluta-
thione peroxidase 1 C593T polymorphism was associated
with lobar ICH in a Polish population [41]. A case–control
study suggested that the rs2228048 of TGFBR2 gene may
be associated with development of ICH in Korean popula-
tion [42]. A study suggested that the rs17222919 of
ALOX5AP may be associated with the development of
ICH in Korean population [43].Figure 4 Egger’s publication bias plot of APOE alleles and ICH.The APOE gene polymorphisms are associated with
many other diseases. A meta-analysis showed that
APOE ε4 allele appeared to be associated with a higher
prevalence of dementia in Parkinson disease [44]. A
meta-analysis suggested that the APOE ε4 isoform was
a genetic factor that might influence the age at onset of
temporal lobe epilepsy [45]. A meta-analysis showed
that the APOE ε4 allele was associated with an in-
creased risk of developing hypertension [46]. A meta-
analysis found that the APOE ε4 allele was associated
with a moderately increased risk for progression from
mild cognitive impairment to Alzheimer's disease-type
dementia [47]. Prevalence of APOE ε4 alleles was sig-
nificantly higher in patients with coronary artery dis-
ease than controls [48].
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APOE polymorphism and the risk of ICH remains un-
clear. APOE plays a critical role in redistributing lipids
among central nervous system cells for normal lipid
homeostasis [49], repairing injured neurons [50], main-
taining synaptodendritic connections [51], neurite out-
growth [52], synaptic plasticity [53], mitochondrial
resistance to oxidative stress [54], and glucose use by
neurons and glial cells [25]. Compared with ε3/ε3, ε4
allele-containing genotypes are associated with increased
total cholesterol levels [13]. It appears that the ε4 allele
enhances amyloid deposition in blood vessels [55]. Thus,
one might expect ε4 carriers to have increased suscepti-
bility to ICH, especially in a lobar location. Furthermore,
APOE ε4 allele was also associated with an increased risk
of developing hypertension [46], which may be the rea-
son that APOE ε4 allele was associated with a higher risk
of ICH.
Several limitations of our meta-analysis should be
noted. First of all, meta-analysis is powerful but also
controversial-controversial because several conditions
are critical to a sound meta-analysis, and small violations
of those conditions can lead to misleading results [56].
Second, relatively small sample size of studies in overall
comparisons was observed in this meta-analysis. The re-
sults of small meta-analyses should be regarded with
caution, even if the P value shows extreme statistical sig-
nificance [57]. Thirdly, because of the lack of individual
patient data, we could not perform an adjustment esti-
mate. In spite of these limitations, our meta-analysis also
had some advantages. First, the major strengths of the
meta-analysis are that we used a comprehensive search-
ing strategy based on computer-assisted and manual
searching which allowed the eligible studies to be in-
cluded as far as possible. Second, no heterogeneity or
publication bias was found, which leads to a possibly ro-
bust result.
In conclusion, our meta-analysis suggested that APOE
ε4 allele was associated with a higher risk of ICH. Future
studies will be required to clarify the biological implica-
tions of our findings.
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